Rogers K V, Dunn C K, Conklin R L, Hadfield S, Petty B A, Brown E M, Hebert S C, Nemeth E F, Fox J
Department of Molecular Biology, NPS Pharmaceuticals, Inc., Salt Lake City, Utah 84108, USA.
Endocrinology. 1995 Feb;136(2):499-504. doi: 10.1210/endo.136.2.7835282.
The level of extracellular ionized calcium ([Ca2+]o) is the primary physiological regulator of PTH secretion. Complementary DNAs encoding the calcium receptor (CaR) protein that mediates this response have been cloned from bovine and human parathyroid glands. This protein is a seven-transmembrane, G-protein-coupled receptor linked to the mobilization of intracellular Ca2+ in response to increases in [Ca2+]o. More recently, a rat kidney CaR has been cloned and shown to be 92% identical at the amino acid level to the bovine parathyroid CaR. Homologous or heterologous regulation of the expression and/or function of a variety of G-protein-coupled receptors has been documented in numerous cell types. Therefore, we determined whether [Ca2+]o and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], major regulators of PTH synthesis and secretion, affect CaR gene expression in parathyroid gland and kidney in rats. CaR messenger RNA (mRNA) levels were quantified in pairs of parathyroid glands and single kidneys from individual animals using a solution hybridization assay. The effects of Ca2+ and 1,25-(OH)2D3 on CaR gene expression were assessed independently in vitamin D-deficient (-D) rats. A wide range of plasma Ca2+ levels (0.7-1.9 mM) was produced by supplementing -D diets with varying amounts of calcium and by infusing CaCl2 i.v. for 7 days using osmotic minipumps. There was no correlation between plasma Ca2+ levels and steady state CaR mRNA levels in parathyroid gland (r = -0.18) or kidney (r = 0.25). In another group of -D rats, 1,25-(OH)2D3 was infused sc at 25 and 275 ng/kg.day for 10-12 days. Dietary calcium was adjusted to maintain normocalcemia in some of the groups. No effect of 1,25-(OH)2D3 administration on CaR mRNA levels occurred in parathyroid glands or kidney regardless of the resultant plasma Ca2+ or 1,25-(OH)2D3 levels. In conclusion, neither parathyroid gland nor kidney CaR mRNA levels are regulated by plasma Ca2+ and 1,25-(OH)2D3 levels in the experimental models examined here.
细胞外游离钙([Ca2+]o)水平是甲状旁腺激素(PTH)分泌的主要生理调节因子。介导这种反应的编码钙受体(CaR)蛋白的互补DNA已从牛和人的甲状旁腺中克隆出来。该蛋白是一种七跨膜、G蛋白偶联受体,与细胞内Ca2+的动员相关,以响应[Ca2+]o的增加。最近,一种大鼠肾脏CaR已被克隆出来,并且在氨基酸水平上与牛甲状旁腺CaR有92%的同一性。在许多细胞类型中,已经记录了多种G蛋白偶联受体的表达和/或功能的同源或异源调节。因此,我们确定了[Ca2+]o和1,25-二羟维生素D3[1,25-(OH)2D3](PTH合成和分泌的主要调节因子)是否影响大鼠甲状旁腺和肾脏中的CaR基因表达。使用溶液杂交分析法对来自个体动物的甲状旁腺对和单个肾脏中的CaR信使核糖核酸(mRNA)水平进行定量。在维生素D缺乏(-D)的大鼠中,独立评估Ca2+和1,25-(OH)2D3对CaR基因表达的影响。通过用不同量的钙补充-D饮食以及使用渗透微型泵静脉注射CaCl2 7天,产生了广泛的血浆Ca2+水平范围(0.7 - 1.9 mM)。甲状旁腺(r = -0.18)或肾脏(r = 0.25)中的血浆Ca2+水平与稳态CaR mRNA水平之间没有相关性。在另一组-D大鼠中,以25和275 ng/kg·天的剂量皮下注射1,25-(OH)2D3,持续10 - 12天。在一些组中调整饮食钙以维持正常血钙水平。无论最终的血浆Ca2+或1,25-(OH)2D3水平如何,给予1,25-(OH)2D3对甲状旁腺或肾脏中的CaR mRNA水平均无影响。总之,在此处研究的实验模型中,甲状旁腺和肾脏的CaR mRNA水平均不受血浆Ca2+和1,25-(OH)2D3水平的调节。